Immunogenic and protective ability of the two developmental forms of Chlamydiae in a mouse model of infertility

Vaccine

Volumn 18, Issue 7-8, 1999, Pages 752-761

  Pal, Sukumar ^a   Rangel, Javier ^a   Peterson, Ellena M ^a   De La Maza, Luis M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chlamydia trachomatis; Infertility; Vaccine

Indexed keywords

BACTERIAL VACCINE; ELEMENTARY BODY; FREUND ADJUVANT; INACTIVATED VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; IMMUNIZATION; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULATE BODY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DISEASE MODELS, ANIMAL; FEMALE; HELA CELLS; HUMANS; IMMUNOGLOBULIN G; INFERTILITY, FEMALE; MALE; MICE; MICE, INBRED BALB C; PNEUMONIA, BACTERIAL; PREGNANCY; VACCINES, INACTIVATED; VAGINA;

EID: 0032728455     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00032-8     Document Type: Article

References (29)

1. Brunham R.C., Binns B., McDowell J., Paraskevas M. Chlamydia trachomatis infection in women with ectopic pregnancy. Obstet Gynecol. 67:1986;722-726.
2. Grayston J.T., Wang S.P. New knowledge of Chlamydiae and the diseases they cause. J Infect Dis. 132:1975;87-105.
3. Punnonen R., Terho P., Nikkanen V., Meuraman O. Chlamydial serology in infertile women by immunofluorescence. Fertil Steril. 31:1979;656-659.
4. Westrom L., Joesoef R., Reynolds G., Hagdu A., Thompson S.E. Pelvic inflammatory disease and fertility: a cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopy. Sex Transm Dis. 19:1992;185-192.
5. Westrom L., Mardh P.A. Chlamydial salpingitis. Br J Bull. 39:1993;145-150.
6. Bavoil P.M., Hsia R.C., Rank R.G. Prospects for a vaccine against Chlamydia genital disease. I. Microbiology and pathogenesis. Bull Inst Pasteur. 9:1996;5-54.
7. de la Maza M.A., de la Maza L.M. A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine. 13:1995;119-127.
8. Grayston J.T., Wang S.P. The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. Sex Transm Dis. 5:1978;73-77.
9. Ward M.E. Chlamydial vaccines-future trends. J Infect. 25:1992;11-26.
10. Schachter J., Dawson C. Human chlamydial infections. 1978;PSG Publishing Company, Littleton, MA.
11. Pal S., Fielder T.J., Peterson E.M., de la Maza L.M. Analysis of the immune response in mice following intrauterine infection with the Chlamydia trachomatis mouse pneumonitis biovar. Infect Immun. 61:1993;772-776.
12. Caldwell H.D., Kromhout J., Schachter J. Purification and characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun. 31:1981;1161-1176.
13. Hatch T.P., Allan I., Pearce J.A. Structural and polypeptide differences between infective and reproductive life cycle forms of Chlamydia spp. J Bacteriol. 157:1984;13-20.
14. Pal S., Fielder T.J., Peterson E.M., de la Maza L.M. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun. 62:1994;3354-3362.
15. Peterson E.M., Zhong G., Carlson E., de la Maza L.M. Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity. Infect Immun. 56:1988;885-891.
16. Schagger H., Von Jagow G. Tricine-sodium dodecyl sulphate polyacrylamide gel electrophoresis for the separation of protein range 1-100 kDa. Anal Biochem. 166:1987;368-379.
17. Geysen H.M., Rodda S.J., Mason T.J., Tribbick G., Schoofs P. Strategies for epitope analysis using peptide synthesis. J Immunol Methods. 102:1987;259-274.
18. Fitch W.M., Peterson E.M., de la Maza L.M. Phylogenetic analysis of the outer membrane protein genes of Chlamydiae and its implications for vaccine development. Molec Biol Evolut. 10:1993;892-913.
19. Roizman B. Introduction: objectives of herpes simplex virus vaccines seen from historical perspective. Rev Infect Dis. 13:1991;S892-894.
20. Peterson E.M., de la Maza L.M. Chlamydia parasitism: ultrastructural characterization of the interaction between the chlamydial cell envelope and the host cell. J Bacteriol. 170:1988;1389-1392.
21. de la Maza L.M., Plunkett M.J., Carlson E.J., Peterson E.M., Czarniecki C.W. Ultrastructural analysis of the anti-chlamydial activity of recombinant murine interferon-γ Exper Mol Pathol. 47:1987;13-25.
22. Beatty P.R., Rasmussen S.J., Stephens R.S. Cross-reactive cytotoxic T-lymphocyte-mediated lysis of Chlamydia trachomatis- and Chlamydia psittaci-infected cells. Infect Immun. 65:1997;951-956.
23. Starnbach M.N., Bevan M.J., Lampe M.F. Protective cytotoxic T-lymphocytes are induced during murine infection with Chlamydia trachomatis. J Immunol. 153:1997;5183-5189.
24. Mazanec M.B., Kaetzel C.S., Lamm M.E., Fletcher D., Nedrud J.G. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA. 89:1992;6901-6905.
25. Smucny J.J., Kelly E.P., MaCarthy P.O., King A.D. Murine immunoglobulin G subclass responses following immunization with live Dengue virus or recombinant Dengue envelope protein. Am J Trop Med Hyg. 53:1995;432-437.
26. Pal S., Theodor I., Peterson E.M., de la Maza L.M. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge. Infect Immun. 65:1997;3361-3369.
27. Slack J., Der-Balian G.P., Nahm M., Davie J.M. Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency. J Exp Med. 151:1980;853-862.
28. Hussain R., Menz B., Dockrell H.M., Chiang T.J. Recognition of Mycobacterium leprae recombinant 18,000 MW epitopes by IgG subclasses in leprosy. Immunology. 84:1995;290-297.
29. Allen J.E., Stephens R.S. An intermolecular mechanisms of T-cell help for the production of antibodies to the bacterial pathogen, Chlamydia trachomatis. Eur J Immunol. 23:1993;1169-1171.